Segment & Geographic Data
API & CSV Delivery
Baird Medical Investment Holdings Limited's Business Segments
Baird Medical Investment Holdings Limited's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
1
Largest Segment
Single Reporting Segment
Total Revenue
$ 22
Regions Reported
4
Annual Results
Revenue Share by Reportable Segment - FY2025
- Single Reporting Segment0%
Revenue by Reportable Segment - FY2025
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Single Reporting Segment | $ 23 | - |
Revenue Share by Country - FY2025
- CN61.7%
- HK36.5%
- MY0.5%
- NP0%
Revenue by Geographic Country - FY2025
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| CN | $ 13 | 61.7% |
| HK | $ 8 | 36.5% |
| MY | $ 0 | 0.5% |
1 more countrys available
Sign in to unlock the full Baird Medical Investment Holdings Limited dataset.
Revenue by Product & Service Category - FY2025
- Microwave Ablation Devices0%
- Microwave Ablation Needles78.7%
- Microwave Ablation Therapeutic Apparatus24.3%
Revenue by Product & Service Category - FY2025
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Microwave Ablation Devices | $ 23 | - |
| Microwave Ablation Needles | $ 17 | 78.7% |
| Microwave Ablation Therapeutic Apparatus | $ 5 | 24.3% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, a Cayman Islands exempted company, operates through its subsidiaries Tycoon, ExcelFin, and Newco. The company was established via a Business Combination Agreement involving Betters Medical Investment Holdings Limited and ExcelFin Acquisition Corp. As part of this agreement, Betters Medical contributed shares of Tycoon to Baird Medical, making Tycoon a wholly-owned subsidiary. Additionally, ExcelFin merged with Merger Sub 1, and Newco merged with Merger Sub 2, both becoming wholly-owned subsidiaries of Baird Medical. The company is governed by various agreements related to shareholder support, lock-ups, and registration rights. Baird Medical's operations include a production plant in Nanjing, China, supporting its manufacturing activities. The company's shares and warrants were structured through ExcelFin’s initial public offering and private placements. Baird Medical focuses on managing and operating its subsidiaries formed through strategic mergers and share contributions, with an emphasis on medical-related investments and production facilities.
The Company operates a single segment focused on the sales of MWA and other medical devices. The Chief Executive Officer reviews consolidated financial results for resource allocation and performance assessment. The Company does not differentiate between markets for these purposes. Its operations and long-lived assets are primarily located in the People's Republic of China, with no significant long-lived assets elsewhere. Accordingly, the Company has one operating and one reportable segment in accordance with ASC 280, Segment Reporting.